Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-04 Purchase | 2021-05-04 4:30 pm | Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director 10% Owner | 400,000 | $16 | $6,400,000 | 5,630,385 (Indirect Direct) | View |
| 2020-04-13 Purchase | 2020-04-13 5:15 pm | Keros Therapeutics Inc. | KROS | Lazarus Alon Director 10% Owner | 120,000 | $16 | $1,920,000 | 2,036,140 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-21 Option Award | 2023-06-23 4:52 pm | N/A 2033-06-20 | Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director | 13,200 | $0 | 13,200 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:39 pm | N/A 2032-05-31 | Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director | 11,600 | $0 | 11,600 (Direct) | View |
| 2021-04-30 Option Award | 2021-05-04 4:30 pm | N/A 2031-04-29 | Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director 10% Owner | 23,200 | $0 | 5,630,385 (Direct) | View |
| 2021-05-04 Conversion | 2021-05-04 4:30 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director 10% Owner | 15,921,469 | $0 | 5,630,385 (Indirect) | View |
Ownership | 2021-04-29 4:49 pm | N/A N/A | Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director 10% Owner | 0 | $0 | 1,646,634 (Indirect) | View |
| 2020-04-13 Conversion | 2020-04-13 5:15 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lazarus Alon Director 10% Owner | 1,893,102 | $0 | 2,036,140 (Indirect) | View |
Ownership | 2020-04-07 7:33 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Lazarus Alon Director 10% Owner | 0 | $0 | 1,916,140 (Direct) | View |